United States Mesenchymal Stem Cells Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Mesenchymal Stem Cells Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Mesenchymal Stem Cells Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Mesenchymal Stem Cells Overall Market Size
2.1 United States Mesenchymal Stem Cells Market Size: 2021 VS 2027
2.2 United States Mesenchymal Stem Cells Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Mesenchymal Stem Cells Players in United States Market
3.2 Top United States Mesenchymal Stem Cells Companies Ranked by Revenue
3.3 United States Mesenchymal Stem Cells Revenue by Companies
3.4 Top 3 and Top 5 Mesenchymal Stem Cells Companies in United States Market, by Revenue in 2020
3.5 Companies Mesenchymal Stem Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mesenchymal Stem Cells Players in United States Market
3.6.1 List of Tier 1 Mesenchymal Stem Cells Companies in United States
3.6.2 List of Tier 2 and Tier 3 Mesenchymal Stem Cells Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Mesenchymal Stem Cells Market Size Markets, 2021 & 2027
4.1.2 Human MSC
4.1.3 Mouse MSC
4.1.4 Rat MSC
4.1.5 Others
4.2 By Type - United States Mesenchymal Stem Cells Revenue & Forecasts
4.2.1 By Type - United States Mesenchymal Stem Cells Revenue, 2016-2021
4.2.2 By Type - United States Mesenchymal Stem Cells Revenue, 2022-2027
4.2.3 By Type - United States Mesenchymal Stem Cells Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Mesenchymal Stem Cells Market Size, 2021 & 2027
5.1.2 Research Institute
5.1.3 Hospital
5.1.4 Others
5.2 By Application - United States Mesenchymal Stem Cells Revenue & Forecasts
5.2.1 By Application - United States Mesenchymal Stem Cells Revenue, 2016-2021
5.2.2 By Application - United States Mesenchymal Stem Cells Revenue, 2022-2027
5.2.3 By Application - United States Mesenchymal Stem Cells Revenue Market Share, 2016-2027
6 Mesenchymal Stem Cells Companies Profiles
6.1 Lonza
6.1.1 Lonza Company Details
6.1.2 Lonza Business Overview
6.1.3 Lonza Mesenchymal Stem Cells Introduction
6.1.4 Lonza Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.1.5 Lonza Recent Developments
6.2 Thermo Fisher
6.2.1 Thermo Fisher Company Details
6.2.2 Thermo Fisher Business Overview
6.2.3 Thermo Fisher Mesenchymal Stem Cells Introduction
6.2.4 Thermo Fisher Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.2.5 Thermo Fisher Recent Developments
6.3 Bio-Techne
6.3.1 Bio-Techne Company Details
6.3.2 Bio-Techne Business Overview
6.3.3 Bio-Techne Mesenchymal Stem Cells Introduction
6.3.4 Bio-Techne Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.3.5 Bio-Techne Recent Developments
6.4 ATCC
6.4.1 ATCC Company Details
6.4.2 ATCC Business Overview
6.4.3 ATCC Mesenchymal Stem Cells Introduction
6.4.4 ATCC Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.4.5 ATCC Recent Developments
6.5 MilliporeSigma
6.5.1 MilliporeSigma Company Details
6.5.2 MilliporeSigma Business Overview
6.5.3 MilliporeSigma Mesenchymal Stem Cells Introduction
6.5.4 MilliporeSigma Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.5.5 MilliporeSigma Recent Developments
6.6 PromoCell GmbH
6.6.1 PromoCell GmbH Company Details
6.6.2 PromoCell GmbH Business Overview
6.6.3 PromoCell GmbH Mesenchymal Stem Cells Introduction
6.6.4 PromoCell GmbH Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.6.5 PromoCell GmbH Recent Developments
6.7 Genlantis
6.7.1 Genlantis Company Details
6.7.2 Genlantis Business Overview
6.7.3 Genlantis Mesenchymal Stem Cells Introduction
6.7.4 Genlantis Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.7.5 Genlantis Recent Developments
6.8 Celprogen
6.8.1 Celprogen Company Details
6.8.2 Celprogen Business Overview
6.8.3 Celprogen Mesenchymal Stem Cells Introduction
6.8.4 Celprogen Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.8.5 Celprogen Recent Developments
6.9 Cell Applications
6.9.1 Cell Applications Company Details
6.9.2 Cell Applications Business Overview
6.9.3 Cell Applications Mesenchymal Stem Cells Introduction
6.9.4 Cell Applications Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.9.5 Cell Applications Recent Developments
6.10 Cyagen Biosciences
6.10.1 Cyagen Biosciences Company Details
6.10.2 Cyagen Biosciences Business Overview
6.10.3 Cyagen Biosciences Mesenchymal Stem Cells Introduction
6.10.4 Cyagen Biosciences Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.10.5 Cyagen Biosciences Recent Developments
6.11 Axol Bioscience
6.11.1 Axol Bioscience Company Details
6.11.2 Axol Bioscience Business Overview
6.11.3 Axol Bioscience Mesenchymal Stem Cells Introduction
6.11.4 Axol Bioscience Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.11.5 Axol Bioscience Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Mesenchymal Stem Cells Market Opportunities & Trends in United States Market
Table 2. Mesenchymal Stem Cells Market Drivers in United States Market
Table 3. Mesenchymal Stem Cells Market Restraints in United States Market
Table 4. Key Players of Mesenchymal Stem Cells in United States Market
Table 5. Top Mesenchymal Stem Cells Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Mesenchymal Stem Cells Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Mesenchymal Stem Cells Revenue Share by Companies, 2016-2021
Table 8. Companies Mesenchymal Stem Cells Product Type
Table 9. List of Tier 1 Mesenchymal Stem Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Mesenchymal Stem Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Mesenchymal Stem Cells Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Mesenchymal Stem Cells Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Mesenchymal Stem Cells Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Mesenchymal Stem Cells Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Mesenchymal Stem Cells Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Mesenchymal Stem Cells Revenue (US$, Mn), 2022-2027
Table 17. Lonza Company Details
Table 18. Lonza Business Overview
Table 19. Lonza Mesenchymal Stem Cells Product
Table 20. Lonza Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Lonza Recent Developments
Table 22. Thermo Fisher Company Details
Table 23. Thermo Fisher Business Overview
Table 24. Thermo Fisher Mesenchymal Stem Cells Product
Table 25. Thermo Fisher Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Thermo Fisher Recent Developments
Table 27. Bio-Techne Company Details
Table 28. Bio-Techne Business Overview
Table 29. Bio-Techne Mesenchymal Stem Cells Product
Table 30. Bio-Techne Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Bio-Techne Recent Developments
Table 32. ATCC Company Details
Table 33. ATCC Business Overview
Table 34. ATCC Mesenchymal Stem Cells Product
Table 35. ATCC Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. ATCC Recent Developments
Table 37. MilliporeSigma Company Details
Table 38. MilliporeSigma Business Overview
Table 39. MilliporeSigma Mesenchymal Stem Cells Product
Table 40. MilliporeSigma Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. MilliporeSigma Recent Developments
Table 42. PromoCell GmbH Company Details
Table 43. PromoCell GmbH Business Overview
Table 44. PromoCell GmbH Mesenchymal Stem Cells Product
Table 45. PromoCell GmbH Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. PromoCell GmbH Recent Developments
Table 47. Genlantis Company Details
Table 48. Genlantis Business Overview
Table 49. Genlantis Mesenchymal Stem Cells Product
Table 50. Genlantis Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Genlantis Recent Developments
Table 52. Celprogen Company Details
Table 53. Celprogen Business Overview
Table 54. Celprogen Mesenchymal Stem Cells Product
Table 55. Celprogen Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Celprogen Recent Developments
Table 57. Cell Applications Company Details
Table 58. Cell Applications Business Overview
Table 59. Cell Applications Mesenchymal Stem Cells Product
Table 60. Cell Applications Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Cell Applications Recent Developments
Table 62. Cyagen Biosciences Company Details
Table 63. Cyagen Biosciences Business Overview
Table 64. Cyagen Biosciences Mesenchymal Stem Cells Product
Table 65. Cyagen Biosciences Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Cyagen Biosciences Recent Developments
Table 67. Axol Bioscience Company Details
Table 68. Axol Bioscience Business Overview
Table 69. Axol Bioscience Mesenchymal Stem Cells Product
Table 70. Axol Bioscience Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Axol Bioscience Recent Developments
List of FiguresFigure 1. Mesenchymal Stem Cells Segment by Type
Figure 2. Mesenchymal Stem Cells Segment by Application
Figure 3. United States Mesenchymal Stem Cells Market Overview: 2020
Figure 4. United States Mesenchymal Stem Cells Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Mesenchymal Stem Cells Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Mesenchymal Stem Cells Revenue in 2020
Figure 7. By Type - United States Mesenchymal Stem Cells Revenue Market Share, 2016-2027
Figure 8. By Application - United States Mesenchymal Stem Cells Revenue Market Share, 2016-2027
Figure 9. Lonza Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Thermo Fisher Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Bio-Techne Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. ATCC Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. MilliporeSigma Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. PromoCell GmbH Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Genlantis Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Celprogen Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Cell Applications Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Cyagen Biosciences Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Axol Bioscience Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)